• In the past quarter, Air Products and Chemicals, Inc. reported second-quarter 2026 sales of US$3,171.8 million and net income of US$710.4 million, marking a return to profit from a very large net loss a year earlier.
• Beyond the headline earnings rebound, Air Products' largest-ever semiconductor investment with Samsung in South Korea underscores how its gas infrastructure is increasingly tied to advanced electronics manufacturing.
• We’ll now examine how this sharp earnings recovery, alongside the Samsung semiconductor supply deal, may influence Air Products’ investment narrative.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 17 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

Air Products and Chemicals Investment Narrative Recap

To own Air Products today, you need to believe its heavy investment in large, long-life gas and hydrogen projects will translate into resilient earnings and dividend capacity, despite high capital demands and project timing risk. The sharp swing back to profit in the latest quarter is encouraging, but does not materially change the near term focus on whether big capital projects can be delivered without overruns or delays that keep returns on capital under pressure.

The Samsung semiconductor supply deal stands out here, because it directly supports Air Products’ push into electronics and long term, on site contracts that can help counterbalance periods when large clean hydrogen and ammonia projects weigh on cash flow. It also sits alongside smaller but relevant capacity additions, such as the new air separation unit planned in Cocoa, Florida, which together point to how the company is trying to build a broader base of contracted and merchant volumes while its mega projects remain under construction.

Yet while the Samsung project looks reassuring, investors should still be aware that delays in bringing major projects like NEOM, Darrow, Edmonton and Rotterdam online could...

Air Products and Chemicals' narrative projects $15.4 billion revenue and $3.7 billion earnings by 2029. This requires 7.3% yearly revenue growth and about a $1.6 billion earnings increase from $2.1 billion today.

Uncover how Air Products and Chemicals' forecasts yield a $327.86 fair value, a 11% upside to its current price.

Exploring Other Perspectives

Four members of the Simply Wall St Community currently see fair value for Air Products between US$213.67 and US$327.86 per share. You can compare these varied views with the risk that ongoing capital in process and large clean energy projects may keep returns on capital and free cash flow constrained for longer than expected.

Explore 4 other fair value estimates on Air Products and Chemicals - why the stock might be worth as much as 11% more than the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Air Products and Chemicals research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Air Products and Chemicals research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Air Products and Chemicals' overall financial health at a glance.

Interested In Other Possibilities?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.
• Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 33 best rare earth metal stocks of the very few that mine this essential strategic resource.
• AI is about to change healthcare. These 35 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.